Agriflu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

This Agriflu market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

Market growth during the historic period can be attributed to several factors, including increasing awareness of seasonal influenza vaccination, a growing elderly population, pandemic preparedness initiatives, technological advancements in egg-based vaccines, and global partnerships for distribution.

In the forecast period, growth is expected to be driven by the development of universal flu vaccines, the expansion of immunization programs in developing countries, heightened awareness of influenza risks post-COVID-19, innovations in vaccine delivery systems, and a focus on pediatric and vulnerable populations. Additionally, public-private partnerships will play a key role. Major trends during this period include technological advancements in vaccine development, the creation of next-generation vaccines, innovations in vaccine formulations, and the integration of digital agriculture.

The increasing prevalence of influenza cases is expected to drive the growth of the agriflu market. Influenza is a contagious respiratory illness caused by influenza viruses, and its prevalence is rising due to factors such as global travel, viral mutations, seasonal changes, limited immunity in populations, and insufficient vaccination coverage in some regions. Agriflu, which provides targeted vaccination for poultry, plays a critical role in controlling the spread of avian influenza, reducing the risk of transmission between birds and to humans. As influenza cases increase globally, the demand for Agriflu to prevent outbreaks and public health threats intensifies. According to the World Health Organization (WHO), there are approximately a billion seasonal influenza cases each year, including 3-5 million severe illnesses. This growing incidence of influenza is driving the agriflu market.

Government initiatives supporting healthcare research and development are expected to propel the agriflu market. These initiatives include actions, programs, and policies aimed at improving healthcare infrastructure and supporting the development of vaccines. For example, in 2022, the UK government announced £260 million (US $270.65 million) in funding to boost healthcare research and manufacturing. This commitment supports the expansion of life sciences manufacturing and the development of new diagnostic tools and vaccines, including those for avian influenza. As governments continue to prioritize healthcare advancements, funding for vaccine development like agriflu is expected to increase, further driving market growth.

The increasing number of immunization programs is propelling the agriflu market. Immunization programs are essential public health initiatives aimed at preventing infectious diseases, and their expansion is a result of growing recognition of their effectiveness, improvements in vaccine technology, and a focus on protecting vulnerable populations. The inclusion of targeted vaccination, such as Agriflu for poultry, in immunization programs helps control the spread of avian influenza, preventing zoonotic transmission to humans and supporting broader public health efforts to mitigate influenza outbreaks. For example, in January 2024, the National Health Service (NHS) in the UK launched a strategy for community-based vaccination services, particularly targeting underserved groups. The growing focus on immunization programs strengthens the demand for vaccines like agriflu, contributing to market growth.

Key player operating in the agriflu market is Sanofi Pasteur S.A.

North America was the largest region in the agriflu market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in agiflu report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the agiflu market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Agiflu is a seasonal influenza vaccine designed to provide protection against the flu virus. It is typically an inactivated, quadrivalent vaccine that helps the immune system recognize and combat influenza viruses.

The primary indications for agiflu include avian influenza (bird flu), foot and mouth disease (FMD), classical swine fever (CSF), and other conditions. Avian influenza, or bird flu, is a viral infection that primarily affects birds, especially wild birds, domestic poultry (such as chickens, ducks, and turkeys), and other avian species. Agiflu is administered via injectable vaccines or nasal spray vaccines. The vaccine is distributed through various channels, including hospitals and clinics, retail and specialty pharmacies, and government and institutional supplies.

The agriflu market research report is one of a series of new reports that provides agriflu market statistics, including agriflu industry global market size, regional shares, competitors with a agriflu market share, detailed agriflu market segments, market trends, and opportunities, and any further data you may need to thrive in the agriflu industry. This agriflu market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The agiflu market consists of the sale of influenza vaccine therapies, including annual flu shots, nasal sprays, and other immunization treatments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.